Showing 441 - 460 results of 693 for search '"Parkinson's disease"', query time: 0.06s Refine Results
  1. 441
    Validity and Reliability of the Persian Version of Parkinson’s Disease Sleep Scale-2

    Validity and Reliability of the Persian Version of Parkinson’s Disease Sleep Scale-2 by Mohammad Taghi Joghataei, Seyed-Mohammad Fereshtehnejad, Maryam Mehdizadeh, Sepideh Goudarzi, Sayed Amir Hasan Habibi, Mahsa Meimandi, Arian Dehmiyani, Ghorban Taghizadeh

    Published 2021-01-01
    “…Parkinson's Disease…”
    Get full text
    Article
    Save to List
    Saved in:
  2. 442
    Effect of Intestinal Levodopa-Carbidopa Infusion on Pharyngeal Dysphagia: Results from a Retrospective Pilot Study in Patients with Parkinson’s Disease

    Effect of Intestinal Levodopa-Carbidopa Infusion on Pharyngeal Dysphagia: Results from a Retrospective Pilot Study in Patients with Parkinson’s Disease by Bendix Labeit, Inga Claus, Paul Muhle, Sonja Suntrup-Krueger, Rainer Dziewas, Tobias Warnecke

    Published 2020-01-01
    “…Parkinson's Disease…”
    Get full text
    Article
    Save to List
    Saved in:
  3. 443
    Cognition Deficits in Parkinson’s Disease: Mechanisms and Treatment

    Cognition Deficits in Parkinson’s Disease: Mechanisms and Treatment by Congcong Fang, Longqin Lv, Shanping Mao, Huimin Dong, Baohui Liu

    Published 2020-01-01
    “…Parkinson's Disease…”
    Get full text
    Article
    Save to List
    Saved in:
  4. 444
    Automated Subfield Volumetric Analysis of Hippocampus in Patients with Drug-Naïve Nondementia Parkinson’s Disease

    Automated Subfield Volumetric Analysis of Hippocampus in Patients with Drug-Naïve Nondementia Parkinson’s Disease by Jin-Woo Park, Chan-Nyoung Lee, Youngbo Sim, Hyung-Kyu Ham, Woo-Suk Tae, Byung-Jo Kim

    Published 2019-01-01
    “…Parkinson's Disease…”
    Get full text
    Article
    Save to List
    Saved in:
  5. 445
    Recurrent Falls in People with Parkinson’s Disease without Cognitive Impairment: Focusing on Modifiable Risk Factors

    Recurrent Falls in People with Parkinson’s Disease without Cognitive Impairment: Focusing on Modifiable Risk Factors by Lorena R. S. Almeida, Guilherme T. Valença, Nádja N. Negreiros, Elen B. Pinto, Jamary Oliveira-Filho

    Published 2014-01-01
    “…Parkinson's Disease…”
    Get full text
    Article
    Save to List
    Saved in:
  6. 446
    Quantitative Analysis of Motor Status in Parkinson’s Disease Using Wearable Devices: From Methodological Considerations to Problems in Clinical Applications

    Quantitative Analysis of Motor Status in Parkinson’s Disease Using Wearable Devices: From Methodological Considerations to Problems in Clinical Applications by Masahiko Suzuki, Hiroshi Mitoma, Mitsuru Yoneyama

    Published 2017-01-01
    “…Parkinson's Disease…”
    Get full text
    Article
    Save to List
    Saved in:
  7. 447
    Pimavanserin Treatment for Parkinson’s Disease Psychosis in Clinical Practice

    Pimavanserin Treatment for Parkinson’s Disease Psychosis in Clinical Practice by Khashayar Dashtipour, Fiona Gupta, Robert A. Hauser, Cherian A. Karunapuzha, John C. Morgan

    Published 2021-01-01
    “…Parkinson's Disease…”
    Get full text
    Article
    Save to List
    Saved in:
  8. 448
    Nicotine Has a Therapeutic Window of Effectiveness in a Drosophila melanogaster Model of Parkinson’s Disease

    Nicotine Has a Therapeutic Window of Effectiveness in a Drosophila melanogaster Model of Parkinson’s Disease by Brady T. Mannett, Braden C. Capt, Krista Pearman, Lori M. Buhlman, John M. VandenBrooks, Gerald B. Call

    Published 2022-01-01
    “…Parkinson's Disease…”
    Get full text
    Article
    Save to List
    Saved in:
  9. 449
    Predictors of Functional and Quality of Life Outcomes following Deep Brain Stimulation Surgery in Parkinson’s Disease Patients: Disease, Patient, and Surgical Factors

    Predictors of Functional and Quality of Life Outcomes following Deep Brain Stimulation Surgery in Parkinson’s Disease Patients: Disease, Patient, and Surgical Factors by Hesham Abboud, Gencer Genc, Nicolas R. Thompson, Srivadee Oravivattanakul, Faisal Alsallom, Dennys Reyes, Kathy Wilson, Russell Cerejo, Xin Xin Yu, Darlene Floden, Anwar Ahmed, Michal Gostkowski, Ayman Ezzeldin, Hazem Marouf, Ossama Y. Mansour, Andre Machado, Hubert H. Fernandez

    Published 2017-01-01
    “…Parkinson's Disease…”
    Get full text
    Article
    Save to List
    Saved in:
  10. 450
    Can a Positive Allosteric Modulation of GABAergic Receptors Improve Motor Symptoms in Patients with Parkinson’s Disease? The Potential Role of Zolpidem in the Treatment of Parkinson’s Disease

    Can a Positive Allosteric Modulation of GABAergic Receptors Improve Motor Symptoms in Patients with Parkinson’s Disease? The Potential Role of Zolpidem in the Treatment of Parkinso... by Antonio Daniele, Francesco Panza, Antonio Greco, Giancarlo Logroscino, Davide Seripa

    Published 2016-01-01
    “…Parkinson's Disease…”
    Get full text
    Article
    Save to List
    Saved in:
  11. 451
    N-Acetylcysteine in Combination with IGF-1 Enhances Neuroprotection against Proteasome Dysfunction-Induced Neurotoxicity in SH-SY5Y Cells

    N-Acetylcysteine in Combination with IGF-1 Enhances Neuroprotection against Proteasome Dysfunction-Induced Neurotoxicity in SH-SY5Y Cells by Benxu Cheng, Pinki Anand, Anxiu Kuang, Feroz Akhtar, Virginia L. Scofield

    Published 2016-01-01
    “…Parkinson's Disease…”
    Get full text
    Article
    Save to List
    Saved in:
  12. 452
    Spinal Cord Pathology in Alpha-Synuclein Transgenic Mice

    Spinal Cord Pathology in Alpha-Synuclein Transgenic Mice by Sonja Mendritzki, Saskia Schmidt, Teresa Sczepan, Xin-Ran Zhu, Daniel Segelcke, Hermann Lübbert

    Published 2010-01-01
    “…Parkinson's Disease…”
    Get full text
    Article
    Save to List
    Saved in:
  13. 453
    Therapeutic Role of Protein Tyrosine Phosphatase 1B in Parkinson’s Disease via Antineuroinflammation and Neuroprotection In Vitro and In Vivo

    Therapeutic Role of Protein Tyrosine Phosphatase 1B in Parkinson’s Disease via Antineuroinflammation and Neuroprotection In Vitro and In Vivo by Chien-Wei Feng, Nan-Fu Chen, Te-Fu Chan, Wu-Fu Chen

    Published 2020-01-01
    “…Parkinson's Disease…”
    Get full text
    Article
    Save to List
    Saved in:
  14. 454
    Gastrointestinal Dysfunctions Are Associated with IL-10 Variants in Parkinson’s Disease

    Gastrointestinal Dysfunctions Are Associated with IL-10 Variants in Parkinson’s Disease by Li Shu, Dongxiao Liang, Hongxu Pan, Qian Xu, Xinxiang Yan, Beisha Tang, Qiying Sun

    Published 2018-01-01
    “…Parkinson's Disease…”
    Get full text
    Article
    Save to List
    Saved in:
  15. 455
    Executive Function and Postural Instability in People with Parkinson’s Disease

    Executive Function and Postural Instability in People with Parkinson’s Disease by Dong Xu, Michael H. Cole, Kerrie Mengersen, Peter A. Silburn, Feng Qiu, Cara Graepel, Graham K. Kerr

    Published 2014-01-01
    “…Parkinson's Disease…”
    Get full text
    Article
    Save to List
    Saved in:
  16. 456
    Sacral Reflex Characteristics of Patients with Multiple System Atrophy

    Sacral Reflex Characteristics of Patients with Multiple System Atrophy by Zhifang Pan, Xueming Zhang, Xun Wang, Binbin Deng, Wanli Zhang, Huanjie Huang

    Published 2020-01-01
    “…Parkinson's Disease…”
    Get full text
    Article
    Save to List
    Saved in:
  17. 457
    Influence of N6-Methyladenosine Modification Gene HNRNPC on Cell Phenotype in Parkinson’s Disease

    Influence of N6-Methyladenosine Modification Gene HNRNPC on Cell Phenotype in Parkinson’s Disease by Wei Quan, Jia Li, Li Liu, Qinghui Zhang, Yidan Qin, Xiaochen Pei, Jiajun Chen

    Published 2021-01-01
    “…Parkinson's Disease…”
    Get full text
    Article
    Save to List
    Saved in:
  18. 458
    Diagnostic Test to Identify Parkinson’s Disease from the Blood Sera of Chinese Population: A Cross-Sectional Study

    Diagnostic Test to Identify Parkinson’s Disease from the Blood Sera of Chinese Population: A Cross-Sectional Study by Guangan Tong, Pingping Zhang, Wenbin Hu, Kun Zhang, Xianwen Chen

    Published 2022-01-01
    “…Parkinson's Disease…”
    Get full text
    Article
    Save to List
    Saved in:
  19. 459
    Dosing Patterns during Conversion to IPX066, Extended-Release Carbidopa-Levodopa (ER CD-LD), in Parkinson’s Disease with Motor Fluctuations

    Dosing Patterns during Conversion to IPX066, Extended-Release Carbidopa-Levodopa (ER CD-LD), in Parkinson’s Disease with Motor Fluctuations by John C. Morgan, Rohit Dhall, Robert Rubens, Sarita Khanna, Suneel Gupta

    Published 2018-01-01
    “…Parkinson's Disease…”
    Get full text
    Article
    Save to List
    Saved in:
  20. 460
    Effectiveness of an Inpatient Movement Disorders Program for Patients with Atypical Parkinsonism

    Effectiveness of an Inpatient Movement Disorders Program for Patients with Atypical Parkinsonism by Anna D. Hohler, Jyeming M. Tsao, Douglas I. Katz, T. Joy DiPiero, Christina L. Hehl, Alissa Leonard, Valerie Allen, Maura Gardner, Heidi Phenix, Marie Saint-Hilaire, Terry Ellis

    Published 2012-01-01
    “…Parkinson's Disease…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: